OakChart

GSK Plc ADR

GSKHealthcare·Drug Manufacturers - General·United Kingdom·Large·NYSE·Nov 11 • 2:36 PM ET

50.47-0.76 (-1.49%)
2026-11-11 20:36 CET
Market cap
102,689.00 USD m
Revenue, TTM
44,971.30 USD m
Net income, TTM
5,843.89 USD m
Free cash flow, TTM
9,390.70 USD m
EPS diluted, TTM
2.87
P/E
17.59
Compare

Price

GSK against its 20, 50 and 200-day averages
2050200miss
47.5050.0052.5055.005.4M10.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26GSKclose 50.4720-day 50.1350-day 49.30200-day 52.4050.4752w low

18.2% under the 52-week high of 61.70 on 18 Feb 2026. 52-week low 45.81 on 20 Nov 2025. Last 15 sessions, 9.6% high to low

Profile

GSK
52-week range, 29% of the way up
45.8161.69

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.

Employees66841
IPOMar 28, 1980
Beta0.29
ATR, 14d1.26
Rel volume0.51
Short float0.81%
Insider own0.01%
Inst own17.19%

Snapshot

6 groups

Valuation

Index-
Market Cap101.16B
Enterprise Value128.19B
Income5.84B
Sales44.97B
Book/sh12.43
Cash/sh1.96
Dividend Est.1.86 (3.68%)
Dividend TTM1.82 (3.60%)
Dividend Ex-DateNov 13, 2026
Dividend Gr. 3/5Y8.77% -7.68%
Payout46.93%
Employees66841
IPOMar 28, 1980

Ratios

P/E17.59
Forward P/E10.16
PEG2.84
P/S2.25
P/B4.06
P/C25.71
P/FCF10.77
EV/EBITDA9.09
EV/Sales2.85
Quick Ratio0.56
Current Ratio0.86
Debt/Eq1.26
LT Debt/Eq1.16
Option/ShortYes / Yes

Earnings

EPS (ttm)2.87
EPS next Y4.97
EPS next Q0.74
EPS this Y1.81%
EPS next Y3.84%
EPS next 5Y3.57%
EPS past 3/5Y-25.93% 0.08%
Sales past 3/5Y6.03% -0.31%
EPS Y/Y TTM-18.14%
Sales Y/Y TTM6.93%
EPS Q/Q-23.07%
Sales Q/Q3.62%
EarningsOct 28 BMO
EPS/Sales Surpr.9.00% 0.37%

Ownership

Insider Own0.01%
Insider Trans0.00%
Inst Own17.19%
Inst Trans-2.05%
ROA6.57%
ROE25.05%
ROIC10.87%
Gross Margin73.46%
Oper. Margin24.74%
Profit Margin12.99%
SMA200.68%
SMA502.37%
SMA200-3.69%
Trades-

Technical

Shs Outstand2.00B
Shs Float2.00B
Short Float0.81%
Short Ratio3.96
Short Interest16.15M
52W High61.69 -18.20%
52W Low45.81 10.17%
Volatility2.44% 2.05%
ATR (14)1.26
RSI (14)53.43
Beta0.29
Rel Volume0.51
Avg Volume4.07M
Volume1,640,186

Performance

Perf Week-1.34%
Perf Month9.07%
Perf Quarter0.03%
Perf Half Y-1.03%
Perf YTD2.91%
Perf Year4.24%
Perf 3Y46.66%
Perf 5Y14.67%
Perf 10Y26.49%
Recom2.00
Target Price56.57
Prev Close51.23
Price50.47
Change %-1.49%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 29, 2026DowngradeJJefferiesBuy → Hold$55.90+10.8%
Oct 09, 2026InitiatedWWolfe ResearchOutperform$70+38.7%
Sep 15, 2026UpgradeBBerenbergHold → Buy
Sep 09, 2026InitiatedRRBC Capital MktsSector Perform
Jul 24, 2026InitiatedCCitigroupNeutral
Jul 06, 2026UpgradeHHSBC SecuritiesReduce → Hold
Jan 27, 2026InitiatedCCitigroupNeutral
Jan 06, 2026DowngradeBBarclaysEqual Weight → Underweight
Nov 25, 2025UpgradeBBofA SecuritiesUnderperform → Neutral
Jun 03, 2025DowngradeBBerenbergBuy → Hold

Peers

Mkt cap
TickerCompanyMkt cap
SNYSanofi ADR115.07B
PFEPfizer Inc167.40B
AZNAstrazeneca plc286.87B
MRKMerck & Co Inc360.81B
NVSNovartis AG ADR292.94B
BMYBristol-Myers Squibb Co127.97B
JNJJohnson & Johnson674.32B
ABBVAbbvie Inc519.33B
NVONovo Nordisk ADR137.08B
LLYLilly(Eli) & Co1346.29B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Martinez Maria EOfficerAug 20 '26Proposed Sale52.0844,3972,312,107Aug 20 11:19 AM

Held by

AUM
TickerCompanyAUM
AVDEAvantis International Equity ETFAUM: 19.73B
FENIFidelity Enhanced International ETFAUM: 11.73B
PPHVanEck Pharmaceutical ETFAUM: 1.09B
FVDFirst Trust Value Line Dividend Index FundAUM: 8.21B
GMIEGMO International Equity Fund ETF ClassAUM: 241.36M
RODMHartford Multifactor Developed Markets (ex-US) ETFAUM: 1.67B
GMOIGMO International Value ETFAUM: 737.83M
DFAXDimensional World ex U.S. Core Equity 2 ETFAUM: 12.02B
AVIVAvantis International Large Cap Value ETFAUM: 2.09B
BINVBrandes International ETFAUM: 579.41M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-281.4521.3331.02411,82011,77710
2026Q22026-07-281.3421.2400.28811,17711,0209
2026Q12026-04-291.2561.1551.14910,30010,2308
2025Q42026-02-040.6970.6420.41411,77611,4086
2025Q32025-10-291.4571.2571.32411,31811,0358
2025Q22025-07-301.2361.1710.93710,61410,4977
2025Q12025-04-301.2001.0450.98910,0399,7158
2024Q42025-02-050.5810.4890.25610,1829,5389
2024Q32024-10-301.2931.152-0.03710,42310,51710
2024Q22024-07-311.1150.9780.71810,1279,57012
2024Q12024-05-011.0770.9220.6459,1998,8929
2023Q42024-01-310.7360.7360.21110,2549,66311
2023Q32023-11-011.2221.1140.9019,8779,37510
2023Q22023-07-261.0030.8930.9939,2768,7839
2023Q12023-04-260.9230.8280.8868,6678,0697
2022Q42023-02-010.6360.5450.8579,0918,90210

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.2493.2342.95443,82143,958
2020FY3.1843.1763.65846,52846,369
2021FY3.0983.0033.72146,21346,085
2022FY3.4443.2869.02236,14335,566
2023FY3.9503.8392.98038,62137,778
2024FY3.9883.8541.58939,27538,732
2025FY4.7014.5383.85644,63843,638
2026FY-4.786--45,221
2027FY-4.969--46,989
2028FY-5.222--48,602
2029FY-5.616--50,431
2030FY-5.732--50,022

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0482511,80911,59312,017
2026Q4S2026-10-2982511,79211,59311,888
2026Q4S2026-10-2872511,79411,59311,918
2026Q4S2026-10-2671511,91711,52112,312
2026Q4S2026-10-2071511,91311,52112,303
2026Q4S2026-10-1970611,89311,52112,303
2026Q4S2026-10-1671511,89711,52112,317
2026Q4S2026-10-1570611,88411,52112,303
2026Q4S2026-10-1270611,88011,52112,303
2026Q4S2026-10-0971511,92511,52112,306
2026Q4S2026-10-0771511,92511,52112,306
2026Q4S2026-10-0571511,95411,52112,306
2026Q4S2026-10-0271411,99211,76012,306
2026Q4S2026-09-1872212,03411,76012,306

Estimate history

EPS, annual0.9982.432.9543.6583.7219.0222.981.5893.662.8687
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.0370.2560.9890.9371.3240.4141.1490.2881.018
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual38874.19841096.85843061.29443727.0133964.50436120.72237699.27640092.63943051.52144971.3
Period201720182019202020212022202320242025TTM
Sales, quarterly10415.73510402.6099465.01110661.3611526.83511461.00410279.22511286.96911944.103
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1956.51969.1721981.2921992.4032003.4422017.172028.132040.4092006.2752004.5
Period201720182019202020212022202320242025MRQ
Shares, quarterly20402040.4092042.52023.520132006.27520102022.6982004.5
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue44,971.3043,051.5240,092.6437,699.2836,120.7233,964.5043,727.0143,061.2941,096.86
Cost of Goods Sold Incl. D&A11,933.8412,286.6912,108.5511,281.9412,147.8211,487.9114,075.1213,866.0113,195.37
Gross Profit33,037.4630,764.8327,984.0926,417.3423,972.9122,476.5929,651.8929,195.2927,901.49
Selling, General and Administrative Excl. Other21,913.1119,934.4120,749.1217,724.6815,742.1515,043.0719,158.3819,266.2117,235.59
Research and Development9,683.628,170.927,024.136,519.815,956.896,032.085,743.675,415.514,877.59
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income11,124.3510,830.427,234.978,692.668,230.767,433.5210,493.519,929.0810,665.90
Interest Expense1,013.66879.03822.91963.371,049.481,052.111,123.341,141.79942.72
Unusual Expense4,871.202,109.943,154.921,777.562,930.413,157.705,274.322,247.853,972.21
Net Income Before Taxes7,241.429,752.394,446.797,544.086,934.924,904.338,893.137,841.976,359.01
Income Taxes752.221,465.49672.13939.75870.87114.15743.771,215.781,005.39
Consolidated Net Income6,475.778,288.213,770.826,598.126,061.594,835.578,191.686,720.595,394.95
Net Income From Continuing Operations5,843.897,533.063,290.376,125.765,494.974,560.517,372.265,925.814,830.92
Net Income5,843.897,533.063,290.376,125.7618,422.506,030.717,372.265,925.814,830.92
EPS (Recurring)4.544.382.663.5910.035.085.493.743.83
EPS (Basic, Before Extraordinaries)2.913.721.613.029.153.773.702.992.46
EPS (Diluted)2.873.661.592.989.023.723.662.952.43
EBITDA14,098.0213,880.0210,494.6711,544.2210,875.3910,351.9113,508.3212,906.6513,140.70
Non-Operating Income (Expense)2,275.891,910.941,189.641,592.352,684.051,680.624,797.291,302.53608.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-385.48332.55299.26313.29384.33408.21446.41424.46
Price To Earnings Ratio17.6117.6121.7510.074.2615.0010.3016.1916.17
Price To Sales Ratio2.182.341.752.021.992.632.122.742.31
Gross Margin73.4671.4669.8070.0766.3766.1867.8167.8067.89
Operating Margin24.7425.1618.0523.0622.7921.8924.0023.0625.95
Net Margin12.9917.508.2116.2551.0017.7616.8613.7611.75
Shares Outstanding2,004.502,006.282,040.412,028.132,017.172,003.441,992.401,981.291,969.17
Market Capitalization102,689.00102,689.0069,001.5975,531.2471,351.7790,840.4875,385.7595,723.4277,361.51

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue11,944.1011,286.9710,279.2311,461.0011,526.8310,661.369,465.0110,402.61
Cost of Goods Sold Incl. D&A3,050.872,816.042,557.343,509.583,019.612,890.292,425.443,251.38
Gross Profit8,893.238,470.937,721.887,951.428,507.237,771.077,039.577,151.23
Selling, General and Administrative Excl. Other5,440.505,252.224,820.966,399.445,039.874,906.154,345.905,719.71
Research and Development2,518.652,310.012,011.652,843.312,124.112,061.251,759.262,352.99
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income3,452.733,218.712,900.931,551.983,467.362,864.922,693.671,431.53
Interest Expense294.34244.29225.01250.02225.22245.64204.01221.71
Unusual Expense977.093,233.48282.95377.69283.21652.82115.86879.17
Net Income Before Taxes2,603.32479.182,894.191,264.733,306.872,521.832,654.64721.53
Income Taxes311.81-267.11410.95296.57420.78321.74423.1379.46
Consolidated Net Income2,288.83742.262,477.85966.832,891.492,197.422,231.51642.07
Net Income From Continuing Operations2,073.79583.882,340.41845.812,714.811,926.412,045.13530.58
Net Income2,073.79583.882,340.41845.812,714.811,926.412,045.13530.58
EPS (Recurring)1.351.401.250.541.421.161.030.55
EPS (Basic, Before Extraordinaries)1.030.291.160.421.350.951.000.26
EPS (Diluted)1.020.291.150.411.320.940.990.26
EBITDA4,448.633,518.033,524.772,606.594,462.654,412.203,730.092,515.75
Non-Operating Income (Expense)422.02738.24501.23614.41347.95555.36280.83390.88
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Earnings Ratio17.6113.5114.8513.7919.8719.7024.2021.75
Price To Sales Ratio2.182.392.562.322.101.931.991.75
Gross Margin74.4675.0575.1269.3873.8072.8974.3768.74
Operating Margin28.9128.5228.2213.5430.0826.8728.4613.76
Net Margin17.365.1722.777.3823.5518.0721.615.10
Shares Outstanding2,004.502,022.702,010.002,006.282,013.002,023.502,042.502,040.41
Market Capitalization102,689.00105,042.87110,384.4298,917.1186,862.5277,730.8278,793.2969,001.59

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments4,581.244,873.096,606.019,475.245,871.548,707.476,340.255,040.915,382.59
Short Term Receivables9,918.408,685.399,437.348,558.6310,877.599,929.529,469.318,051.708,048.86
Inventories7,968.087,099.867,008.856,190.127,832.788,196.237,878.296,974.237,517.23
Other Current Assets1,084.11628.70715.16759.03711.09843.412,132.851,491.39569.51
Total Current Assets23,551.8321,287.0423,767.3724,983.0325,293.0027,676.6425,820.7021,558.2321,518.19
Net Property, Plant & Equipment13,515.0612,615.4312,693.1811,571.9014,454.6915,044.6514,988.2214,083.4714,690.86
Total Investments and Advances1,514.531,544.211,553.981,894.573,082.734,778.862,985.992,072.151,500.20
Long-Term Note Receivable1,389.441,262.421,176.641,119.901,206.8147.84198.71179.58307.07
Intangible Assets31,966.4628,175.2427,508.9125,698.7655,032.6655,253.4954,999.6529,281.3431,513.66
Deferred Tax Assets8,769.738,462.477,711.276,806.017,067.525,860.115,426.184,950.485,135.04
Other Assets1,499.731,124.66808.22275.461,003.651,283.571,152.531,827.621,604.36
Total Assets82,206.7774,471.4675,219.5772,349.62107,141.06109,945.16105,571.9873,952.8676,269.40
Short Term Debt Incl. Current Port. of LT Debt4,051.292,941.893,586.014,753.864,877.375,091.899,164.627,377.963,821.52
Accounts Payable4,754.754,335.814,738.434,650.416,142.435,955.805,489.764,642.274,772.50
Income Tax Payable669.83880.44637.40566.57662.33744.99833.271,229.021,345.99
Other Current Liabilities19,296.0919,015.1917,895.6417,467.3120,377.7018,482.5316,372.5915,395.2826,001.21
Total Current Liabilities28,771.9627,173.3226,857.4927,438.1532,059.8330,275.2131,860.2428,644.5435,941.21
Long Term Debt19,783.0018,331.3819,383.3320,491.4027,863.7532,020.8031,250.8525,817.1519,295.63
Provision for Risks Charges4,294.743,072.143,614.063,742.225,069.715,955.805,467.244,860.065,647.73
Deferred Tax Liabilities391.41478.42396.46347.644,816.424,921.025,047.301,472.281,888.44
Other Liabilities7,504.039,027.308,657.178,185.738,424.688,328.837,627.918,482.188,776.64
Total Liabilities60,745.1558,082.5558,908.5160,205.1478,234.3981,501.6681,253.5469,276.2071,549.65
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity22,027.8817,121.5617,014.7612,748.3320,391.2419,939.7015,108.775,552.90-91.99
Total Shareholders Equity22,027.8817,121.5617,014.7612,748.3320,391.2419,939.7015,108.775,552.90-91.99
Accumulated Minority Interest-566.27-732.65-703.69-603.868,515.438,503.809,209.66-876.244,811.73
Total Equity21,461.6216,388.9116,311.0712,144.4828,906.6728,443.5024,318.444,676.664,719.74
Total Liabilities & Stockholders Equity82,206.7774,471.4675,219.5772,349.62107,141.06109,945.16105,571.9873,952.8676,269.40
Book Value Per Share10.988.398.396.3210.1810.017.632.82-0.05
Tangible Book Value Per Share-4.95-5.42-5.17-6.42-17.29-17.72-20.13-12.05-16.15
Full-Time Employees66,84168,62970,21269,40090,09694,06699,43795,49098,462
Price to Book Ratio4.123.674.696.944.453.786.3413.9341.09
Return on Assets9.624.408.306.124.206.846.606.432.64
Return on Equity38.4819.2841.1633.1622.6242.0757.36176.93304.26
Return on Invested Capital18.029.2816.8355.4212.5014.1912.7815.4010.27
Quick Ratio0.540.520.620.680.540.640.560.510.39
Current Ratio0.820.780.880.910.790.910.810.750.60

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income6,447.278,288.213,770.826,598.126,061.594,835.578,191.686,720.595,394.95
Depreciation3,308.023,049.603,259.702,851.562,644.632,918.393,014.822,977.572,474.80
Other Funds (Non Cash)1,813.431,166.331,736.55580.512,092.792,873.01-2,023.56-608.5357.34
Funds from Operations11,568.7112,131.187,456.038,954.959,833.309,460.728,294.278,856.187,375.06
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-181.65-2,506.63327.12-1,064.05-1,672.76445.601,511.90347.002,980.16
Cash from Operating Activities11,387.079,624.557,783.157,890.898,160.549,906.319,806.179,203.1810,355.22
Capital Expenditures-3,539.13-3,933.90-3,810.44-2,913.71-2,781.36-3,650.06-2,871.19-2,759.42-2,394.79
Net Assets From Acquisitions-16,204.31-2,265.45-1,077.20-1,824.80-3,978.65-180.16-153.88-4,708.75-12,631.34
Sale of Fixed Assets and Businesses708.0931.6394.56104.42189.69191.17442.41253.87286.68
Purchase or Sale of Investments223.99142.332,850.802,215.12117.02459.353,658.56-253.87-220.01
Purchase of Investments-137.44-121.25-186.56-152.90-177.38-224.17-533.46-343.17-425.36
Sale Or Maturity of Investments361.43263.583,037.362,368.01294.40683.534,192.0289.30205.34
Other Uses-137.02-22.400.000.00-4,669.68-167.790.000.000.00
Other Sources482.35151.56167.3914.92241.43881.571,609.36515.40341.35
Cash from Investing Activities-16,621.92-5,896.24-1,774.88-2,404.06-10,881.55-2,465.922,685.25-6,952.78-14,618.11
Cash Dividends Paid-3,606.88-3,379.07-3,122.97-2,793.14-4,270.58-5,499.84-5,099.92-5,043.00-5,236.28
Change in Capital Stock-1,168.22-1,794.9725.5612.4330.7928.8837.1965.0698.67
Repurchase of Common Pref Stock-1,181.59-1,814.730.000.000.000.000.000.000.00
Sale of Common Pref Stock13.3719.7725.5612.4330.7928.8837.1965.0698.67
Proceedsfrom Stock Options13.3719.7725.5612.4330.7928.8837.1965.0698.67
Issuance or Reduction of Debt, Net8,753.701,984.74-1,489.93-2,946.03-5,693.29-2,754.73-5,138.404,757.2310,832.60
Change in Long Term Debt8,491.60763.06-690.0298.20-700.880.004,229.216,115.8913,480.72
Issuance of Long Term Debt10,455.142,608.101,373.65277.201,262.570.004,229.216,115.8913,518.05
Reduction of Long Term Debt-1,963.54-1,845.05-2,063.67-179.00-1,963.460.000.000.00-37.34
Net Financing Active Other Cash Flow-325.66-454.67-366.73-96.9612,230.35-910.45-1,396.48-702.93-793.38
Other Financing Activities Uses-623.18-515.30-531.57-512.14-641.76-965.46-1,549.08-702.93-793.38
Cash from Financing Activities5,171.55-3,961.58-5,242.86-6,068.582,048.45-9,385.07-11,888.71-1,196.644,901.59
Exchange Rate Effect-106.78-25.04-69.00-123.06187.23-39.88-50.01-104.6110.67
Net Change in Cash-170.08-258.31696.41-704.81-485.32-1,984.56552.69949.15649.37
Free Cash Flow9,390.707,848.045,995.506,257.526,752.628,599.788,234.007,589.378,563.12
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow16.9622.5924.3821.9928.9128.8229.5846.2828.55
Deferred Taxes & Investment Tax Credit--372.96-1,311.04-1,075.24-965.72-1,166.26-888.67-233.46-552.03

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments3,934.874,122.444,540.284,581.244,450.704,959.30
Short Term Receivables11,325.0410,716.2210,466.529,918.4011,179.2610,547.58
Inventories8,369.248,337.788,119.247,968.088,236.368,320.77
Other Current Assets143.47128.74295.391,084.11153.47390.55
Total Current Assets23,772.6123,305.1823,421.4323,551.8324,019.7924,218.20
Net Property, Plant & Equipment13,446.5713,314.9713,237.1113,515.0613,640.2013,591.13
Total Investments and Advances1,218.191,290.091,288.371,514.531,457.991,338.83
Intangible Assets44,354.2932,096.8933,527.9531,966.4632,285.7730,298.44
Deferred Tax Assets8,947.118,413.448,317.048,769.738,303.679,018.27
Other Assets3,509.763,521.193,113.451,499.732,870.202,739.33
Total Assets95,248.5481,941.7682,905.3582,206.7782,577.6381,204.20
Short Term Debt Incl. Current Port. of LT Debt2,658.235,695.236,651.524,051.293,844.892,809.22
Accounts Payable20,767.6619,035.4218,903.5620,688.2121,102.4720,308.59
Income Tax Payable900.69695.48731.88669.83436.19796.17
Other Current Liabilities3,198.913,154.873,290.163,362.623,337.354,011.01
Total Current Liabilities27,525.4828,581.0029,577.1228,771.9628,720.9027,924.99
Long Term Debt28,827.3718,511.1618,477.6219,783.0020,051.0520,971.84
Provision for Risks Charges3,059.422,957.112,998.724,294.743,144.843,188.80
Deferred Tax Liabilities2,218.51402.16385.06391.41525.04526.21
Other Liabilities9,224.768,692.168,492.437,504.038,929.688,922.35
Total Liabilities70,855.5459,143.5959,930.9660,745.1561,371.5061,534.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity24,913.7523,419.3323,541.4322,027.8821,739.2420,268.85
Total Shareholders Equity24,913.7523,419.3323,541.4322,027.8821,739.2420,268.85
Accumulated Minority Interest-520.75-621.15-567.04-566.27-533.12-598.84
Total Equity24,393.0022,798.1722,974.3921,461.6221,206.1319,670.00
Total Liabilities & Stockholders Equity95,248.5481,941.7682,905.3582,206.7782,577.6381,204.20
Book Value Per Share12.4311.5811.7110.9810.8010.02
Tangible Book Value Per Share-9.70-4.29-4.97-4.95-5.24-4.96
Full-Time Employees---66,841--
Price to Book Ratio4.124.485.034.544.314.29
Return on Assets6.577.959.719.619.005.73
Return on Equity25.0529.6937.4438.4835.6123.03
Return on Invested Capital3.861.395.572.026.504.67
Quick Ratio0.560.520.520.540.550.57
Current Ratio0.860.820.790.820.840.87

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income2,296.76733.362,477.85939.302,964.762,184.04
Depreciation998.44297.10623.841,388.641,048.761,524.03
Other Funds (Non Cash)1,050.682,371.40-160.34-1,448.3186.12-617.60
Funds from Operations4,345.883,401.862,941.35879.624,099.643,090.47
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-571.78-16.17-1,457.871,864.17-1,068.32-626.35
Cash from Operating Activities3,774.113,385.691,483.472,743.793,031.322,464.12
Capital Expenditures-719.73-874.46-596.89-1,348.05-1,204.26-832.32
Net Assets From Acquisitions-9,644.87-897.78-3,776.73-1,884.93-1,162.2510.81
Sale of Fixed Assets and Businesses-8.6317.732,503.45-1,804.456.846.49
Purchase or Sale of Investments11.14190.608.0814.16163.59-7.18
Purchase of Investments-51.18-25.48-8.08-52.71-10.87-30.43
Sale Or Maturity of Investments62.32216.0816.1766.87174.4623.25
Other Uses-118.38-5.35-5.39-7.89-6.84-3.97
Other Sources2.26393.0483.543.5250.432.47
Cash from Investing Activities-10,478.21-1,176.22-1,783.94-3,183.55-2,152.49-823.69
Cash Dividends Paid-920.84-972.82-866.37-846.84-906.96-867.37
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-1.61-410.58-428.47-327.56-448.47-729.79
Repurchase of Common Pref Stock-1.63-411.88-439.25-328.83-448.96-732.76
Sale of Common Pref Stock0.021.3010.781.270.492.97
Proceedsfrom Stock Options0.021.3010.781.270.492.97
Issuance or Reduction of Debt, Net7,294.26-854.251,592.61721.07-77.51-1,066.67
Change in Long Term Debt9,652.53-1,161.240.000.32-1,796.1120.44
Issuance of Long Term Debt10,463.130.000.00-7.9864.2320.44
Reduction of Long Term Debt-810.60-1,161.240.008.30-1,860.340.00
Net Financing Active Other Cash Flow85.64-233.602.69-180.40-197.20-42.28
Other Financing Activities Uses-137.84-183.35-154.95-147.04-137.68-159.49
Cash from Financing Activities6,395.31-2,542.15229.061,089.33-1,708.30-2,776.44
Exchange Rate Effect-45.74-9.412.69-54.3376.99-33.95
Net Change in Cash-354.53-342.08-68.72595.25-752.48-1,169.96
Free Cash Flow3,269.652,946.451,185.701,988.912,602.382,126.64
Price to Free Cash Flow16.9620.7525.4622.3319.1317.60

Revenue breakdown

Total Pharmaceutical Preparations revenue2024: 40.10B 2025: 43.04B
United Kingdom2024: 40.10B 2025: 43.04B
Total Pharmaceutical Preparations revenue2024: 40.10B 2025: 43.04B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.81%16.1M2004.3M4.08M
2026-10-150.73%14.6M2003.3M4.21M
2026-09-300.74%14.8M2003.3M3.58M
2026-09-150.73%14.7M2003.3M3.63M
2026-08-310.68%13.5M2003.3M3.89M
2026-08-140.74%14.8M2003.3M3.96M
2026-07-310.72%14.5M2003.3M4.01M
2026-07-150.69%13.8M2002.6M3.81M
2026-06-300.64%12.8M2002.6M3.97M
2026-06-150.42%8.4M2003.6M4.06M
2026-05-290.49%9.8M2005.0M4.18M
2026-05-150.68%13.6M1995.0M4.58M
2026-04-300.66%13.2M1996.0M5.28M
2026-04-150.77%15.5M1996.7M5.48M
2026-03-310.80%16.1M1998.3M5.58M
2026-03-130.62%12.4M2001.5M5.23M
2026-02-270.54%10.8M2004.4M4.96M
2026-02-130.65%13.1M2017.1M4.86M
2026-01-300.88%17.7M2017.1M4.29M
2026-01-150.87%17.6M2017.1M4.42M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call30.0018.2020.4021.324.9026.000.000.989-0.0910.001
call35.0013.2017.0016.155.4731.000.000.975-0.1500.002
call37.0013.2013.4013.033.2030.001.000.971-0.1460.002
call38.0010.8014.0012.283.9270.001.000.969-0.1420.003
call39.009.7012.8011.194.0430.002.000.967-0.1410.003
call40.008.3012.0011.324.0342.000.000.964-0.1380.003
call41.007.2011.000.003.8030.000.000.961-0.1340.003
call42.007.109.005.302.4501.000.000.957-0.1300.003
call43.005.209.000.003.2650.000.000.952-0.1260.004
call44.005.207.100.002.1510.000.000.946-0.1190.004
call45.004.505.706.601.43011.000.000.939-0.1160.004
call46.003.605.805.682.1202.000.000.916-0.1410.006
call47.002.754.203.321.50614.001.000.878-0.1610.007
call47.502.303.502.891.2100.001.000.865-0.1540.008
call48.001.752.503.690.5155.000.000.900-0.0900.006
call48.501.303.100.000.9680.000.000.806-0.1600.010
call49.000.851.501.800.2741110.000.842-0.0960.009
call49.500.751.001.800.1991.000.000.776-0.1040.011
call50.000.450.600.420.21427.001.000.644-0.1310.014
call51.000.100.150.100.24214814.000.425-0.2540.014
call52.000.000.100.050.3821821.000.335-0.3150.013
call53.000.000.050.060.55457.000.000.190-0.2020.010
call54.000.000.350.500.7050.000.000.120-0.1540.007
call55.000.000.050.300.86723.000.000.071-0.1060.005
call56.000.000.750.210.8201540.000.042-0.0700.003
call57.000.000.200.000.9410.000.000.037-0.0720.003
call58.000.002.100.001.0510.000.000.034-0.0750.003
call59.000.001.950.001.1400.000.000.032-0.0780.003
call60.000.001.950.001.2490.000.000.029-0.0800.002
call61.000.002.100.001.3480.000.000.027-0.0800.002
call62.000.001.200.001.4340.000.000.026-0.0820.002
call63.000.000.950.001.5350.000.000.024-0.0830.002
call65.000.001.650.001.7010.000.000.022-0.0860.002
call70.000.002.100.002.1030.000.000.019-0.0930.002
put30.000.000.050.053.1410.001.00-0.011-0.0860.001
put35.000.002.000.102.6740.001.00-0.025-0.1480.002
put37.000.000.750.002.3200.000.00-0.029-0.1440.002
put38.000.000.950.002.1490.000.00-0.031-0.1410.003
put39.000.002.100.001.9750.000.00-0.033-0.1380.003
put40.000.000.750.001.8310.000.00-0.036-0.1370.003
put41.000.001.000.001.6510.000.00-0.039-0.1320.003
put42.000.001.000.001.4800.000.00-0.043-0.1280.003
put43.000.001.200.051.3647.000.00-0.047-0.1280.004
put44.000.002.100.081.1863.000.00-0.053-0.1220.004
put45.000.002.150.081.04461.000.00-0.059-0.1180.004
put46.000.001.000.210.8663.000.00-0.089-0.1470.006
put47.000.001.000.100.70635.000.00-0.120-0.1590.007
put47.500.001.000.540.60813.000.00-0.140-0.1570.008
put48.000.050.100.050.55617.001.00-0.088-0.0800.006
put48.500.050.150.000.5350.000.00-0.190-0.1680.010
put49.000.100.200.270.4923.0012.00-0.158-0.0960.009
put49.500.250.300.200.4713.000.00-0.224-0.1030.011
put50.000.450.500.700.49134.006.00-0.356-0.1300.014
put51.000.102.050.601.21499.000.00-0.575-0.2540.014
put52.001.203.601.161.8244.000.00-0.682-0.2980.013
put53.001.703.802.951.4940.001.00-0.811-0.2000.010
put54.003.704.703.871.6450.001.00-0.898-0.1250.006
put55.003.507.300.002.9960.000.00-0.935-0.0940.005
put56.004.508.300.003.2480.000.00-0.958-0.0690.003
put57.005.509.300.003.5180.000.00-0.962-0.0720.003
put58.006.5010.307.083.6411.000.00-0.966-0.0740.003
put59.007.5011.308.003.8421.000.00-0.968-0.0760.003
put60.009.0011.709.073.5341.000.00-0.970-0.0780.002
put61.009.5013.3010.004.1721.000.00-0.972-0.0790.002
put62.0010.5014.300.004.3370.000.00-0.974-0.0810.002
put63.0011.5015.300.004.5040.000.00-0.975-0.0820.002
put65.0013.5017.300.004.7970.000.00-0.977-0.0850.002
put70.0018.5022.300.005.4180.000.00-0.981-0.0880.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-06SEC
2026-11-0513F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-09-30SEC
2026-11-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-02SEC
2026-10-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-28SEC
2026-10-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-26SEC
2026-10-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-26SEC
2026-10-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-26SEC
2026-10-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-26SEC
2026-10-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-21SEC
2026-10-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-19SEC
2026-10-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-19SEC
2026-10-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-15SEC
2026-10-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-14SEC
2026-10-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-13SEC
2026-10-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-13SEC
2026-10-13S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-10-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-08SEC
2026-10-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-06SEC
2026-10-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-01SEC
2026-09-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-24SEC
2026-09-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-22SEC
2026-09-22CERTSEC
2026-09-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-15SEC
2026-09-158-A12BSEC
2026-09-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-15SEC
2026-09-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-14SEC
2026-09-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-14SEC
2026-09-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-11SEC
2026-09-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-10SEC
2026-09-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-10SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
FMR LLC3.24%
DODGE & COX2.41%
Fisher Asset Management, LLC1.76%
PRIMECAP MANAGEMENT CO/CA/1.26%
WELLINGTON MANAGEMENT GROUP LLP0.57%
JTC Employer Solutions Trustee Ltd0.40%
MORGAN STANLEY0.38%
ROYAL BANK OF CANADA0.38%
PRICE T ROWE ASSOCIATES INC /MD/0.35%
GOLDMAN SACHS GROUP INC0.32%

Funds

Fund% owned
Dodge & Cox International Stock Fund3.16%
Dodge & Cox Stock Fund1.78%
VANGUARD PRIMECAP FUND0.91%
Empower Bond Index Fund0.71%
VANGUARD WELLINGTON FUND0.47%
Strategic Advisers Fidelity U.S. Total Stock Fund0.40%
Avantis Core Fixed Income ETF0.37%
Dodge & Cox Global Stock Fund0.37%
Fidelity Series Large Cap Stock Fund0.23%
Fidelity Series Value Discovery Fund0.21%

OakChart. GSK. Cached 15 minutes.